Johnson & Johnson (JNJ) operating KPIs
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)
Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%
Johnson & Johnson deferred tax assets, gross ($M) ($M)
Form 10-K Note 8 (Income Taxes)
Latest, FY2025
14,467
Period ended Dec 28, 2025
Change on a year earlier
-14.0%
16,826 in FY2024
History
4 years
Since FY2017
Sources
3
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Deferred tax assets, gross ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 28, 2025 | 14,467 | -14.0% | Form 10-K (filed 2026-02-11) ↗ |
| FY2024 | Dec 29, 2024 | 16,826 | +21.8% | Form 10-K (filed 2026-02-11) ↗ |
| FY2023 | Dec 31, 2023 | 13,819 | – | Form 10-K (filed 2025-02-13) ↗ |
| FY2017 | Dec 31, 2017 | 1,100 | – | Form 10-K (filed 2019-02-20) ↗ |
Breakdown
What makes up deferred tax assets, gross ($m)
- Deferred tax assets — Capitalized R&D & international R&D ($M)4,752 · FY2025
- Deferred tax assets — Reserves & liabilities ($M)2,433 · FY2025
- Deferred tax assets — Employee & retiree benefits ($M)54 · FY2025
- Deferred tax assets — Net operating loss carryforwards ($M)3,561 · FY2025
- Deferred tax assets — Stock-based compensation ($M)651 · FY2025
- Deferred tax assets — Valuation allowance ($M)1,837 · FY2025
- Deferred tax assets, net of valuation allowance ($M)12,630 · FY2025
- Deferred tax liabilities, total ($M)12,547 · FY2025
Cite this data
StockData. (2026). Johnson & Johnson Deferred tax assets, gross ($M) ($M), annual FY2017–FY2025 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/dta_gross
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.